Peer review reports
From: The pharmacokinetics and pharmacodynamics of danirixin (GSK1325756) − a selective CXCR2 antagonist − in healthy adult subjects
Original Submission |
28 Oct 2014 |
Submitted |
Original manuscript
|
|
Author responded |
Author comments
|
Resubmission - Version 2 |
|
Submitted |
Manuscript version 2
|
|
Author responded |
Author comments
|
|
Reviewed |
Reviewer Report
|
|
Reviewed |
Reviewer Report
|
Resubmission - Version 3 |
|
Submitted |
Manuscript version 3
|
|
Author responded |
Author comments
|
Resubmission - Version 4 |
|
Submitted |
Manuscript version 4
|
|
Author responded |
Author comments
|
Resubmission - Version 5 |
|
Submitted |
Manuscript version 5
|
|
Author responded |
Author comments
|
Resubmission - Version 6 |
|
Submitted |
Manuscript version 6
|
Publishing |
26 May 2015 |
Editorially accepted |
|
20 Jun 2015 |
Article published |
10.1186/s40360-015-0017-x
|
Learn about peer review